187 related articles for article (PubMed ID: 34378486)
1. Immunological and biological dissection of normal and tumoral salivary glands.
Haghshenas MR; Ghaderi H; Daneste H; Ghaderi A
Int Rev Immunol; 2023; 42(2):139-155. PubMed ID: 34378486
[TBL] [Abstract][Full Text] [Related]
2. Chemokine and chemokine receptor patterns in patients with benign and malignant salivary gland tumors: a distinct role for CCR7.
Haghshenas MR; Ashraf MJ; Khademi B; Ghaderi A; Erfani N; Razmkhah M
Eur Cytokine Netw; 2017 Mar; 28(1):27-35. PubMed ID: 28840842
[TBL] [Abstract][Full Text] [Related]
3. [Tumor microenvironment in salivary gland carcinomas: Consequences for new therapeutic concepts].
Meyer MF; Arolt C; Kansy BA; Doescher J; Quaas A; Beutner D; Lang S; Klußmann JP
HNO; 2020 Dec; 68(12):927-934. PubMed ID: 32929519
[TBL] [Abstract][Full Text] [Related]
4. Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules.
Zhou G; Sprengers D; Mancham S; Erkens R; Boor PPC; van Beek AA; Doukas M; Noordam L; Campos Carrascosa L; de Ruiter V; van Leeuwen RWF; Polak WG; de Jonge J; Groot Koerkamp B; van Rosmalen B; van Gulik TM; Verheij J; IJzermans JNM; Bruno MJ; Kwekkeboom J
J Hepatol; 2019 Oct; 71(4):753-762. PubMed ID: 31195061
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte activation gene 3 (LAG3) protein expression on tumor-infiltrating lymphocytes in aggressive and TP53-mutated salivary gland carcinomas.
Arolt C; Meyer M; Ruesseler V; Nachtsheim L; Wuerdemann N; Dreyer T; Gattenlöhner S; Wittekindt C; Buettner R; Quaas A; Klussmann JP
Cancer Immunol Immunother; 2020 Jul; 69(7):1363-1373. PubMed ID: 32232506
[TBL] [Abstract][Full Text] [Related]
6. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
[TBL] [Abstract][Full Text] [Related]
7. The relevance of Fas/Fas ligand axis in the tumor microenvironment of salivary gland adenoid cystic carcinoma.
Kuchar M; Strizova Z; Votava M; Plzak J
Oral Oncol; 2019 Oct; 97():135-136. PubMed ID: 31455593
[No Abstract] [Full Text] [Related]
8. Salivary gland cancer in the setting of tumor microenvironment: Translational routes for therapy.
Lavareze L; Scarini JF; de Lima-Souza RA; Emerick C; Sales de Sá R; Aquino IG; Fernandes PM; Gonçalves MT; Helms MN; Altemani A; Egal ESA; Mariano FV
Crit Rev Oncol Hematol; 2022 Mar; 171():103605. PubMed ID: 35077805
[TBL] [Abstract][Full Text] [Related]
9. Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors.
Eckert F; Zwirner K; Boeke S; Thorwarth D; Zips D; Huber SM
Front Immunol; 2019; 10():407. PubMed ID: 30930892
[TBL] [Abstract][Full Text] [Related]
10. The tumor microenvironment of benign and malignant salivary gland tumors.
Wai KC; Okholm TLH; Ha PK; Marquez DM; Tenvooren I; Jones KB; Spitzer MH
Head Neck; 2024 Jul; 46(7):1625-1636. PubMed ID: 38454566
[TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment in salivary gland carcinomas: An orchestrated state of chaos.
Egal ESA; Scarini JF; de Lima-Souza RA; Lavareze L; Fernandes PM; Emerick C; Gonçalves MT; Helms MN; Altemani A; Mariano FV
Oral Oncol; 2022 Apr; 127():105777. PubMed ID: 35189584
[TBL] [Abstract][Full Text] [Related]
12. The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype.
Linxweiler M; Kuo F; Katabi N; Lee M; Nadeem Z; Dalin MG; Makarov V; Chowell D; Dogan S; Ganly I; Hakimi AA; Wong RJ; Riaz N; Ho AL; Chan TA; Morris LGT
Clin Cancer Res; 2020 Jun; 26(12):2859-2870. PubMed ID: 32060100
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 overexpression in benign and malignant salivary gland tumors.
Jaafari-Ashkavandi Z; Ashraf MJ; Nazhvani AD; Azizi Z
Tumour Biol; 2016 Feb; 37(2):1863-9. PubMed ID: 26323261
[TBL] [Abstract][Full Text] [Related]
14. RANK and RANKL Expression in Salivary Gland Tumors.
Aslan F; Küçük Ü
Ear Nose Throat J; 2020 Aug; 99(7):475-480. PubMed ID: 32525717
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications.
Maruya S; Kies MS; Williams M; Myers JN; Weber RS; Batsakis JG; El-Naggar AK
Hum Pathol; 2005 Jul; 36(7):821-7. PubMed ID: 16084953
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-6 is a marker of serous acinar cell differentiation in normal and neoplastic human salivary gland.
Heikinheimo KA; Laine MA; Ritvos OV; Voutilainen RJ; Hogan BL; Leivo IV
Cancer Res; 1999 Nov; 59(22):5815-21. PubMed ID: 10582704
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of CD8-positive tumour-infiltrating lymphocytes and PD-L1 expression in salivary gland cancer.
Kesar N; Winkelmann R; Oppermann J; Ghanaati S; Martin D; Neumayer T; Balster S; Rödel C; Rödel F; von der Grün J; Balermpas P
Oral Oncol; 2020 Dec; 111():104931. PubMed ID: 32736208
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells.
Sasidharan Nair V; Elkord E
Immunol Cell Biol; 2018 Jan; 96(1):21-33. PubMed ID: 29359507
[TBL] [Abstract][Full Text] [Related]
19. The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities.
Alame M; Cornillot E; Cacheux V; Tosato G; Four M; De Oliveira L; Gofflot S; Delvenne P; Turtoi E; Cabello-Aguilar S; Nishiyama M; Turtoi A; Costes-Martineau V; Colinge J
Theranostics; 2020; 10(10):4383-4394. PubMed ID: 32292502
[No Abstract] [Full Text] [Related]
20. Epithelial CXCR3-B regulates chemokines bioavailability in normal, but not in Sjogren's syndrome, salivary glands.
Sfriso P; Oliviero F; Calabrese F; Miorin M; Facco M; Contri A; Cabrelle A; Baesso I; Cozzi F; Andretta M; Cassatella MA; Fiocco U; Todesco S; Konttinen YT; Punzi L; Agostini C
J Immunol; 2006 Feb; 176(4):2581-9. PubMed ID: 16456020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
